Table 2. Prognosis outcome and stratification analysis.

Variable	CCRT+hysterectomy	CCRT	HR (95% CI)	p-value*
Outcome (median)	34	21
PFS (mo)	48	10	0.343 (0.152-0.772)	0.010
PFS at 3 yr (%)	50.3	31.7
OS (mo)	58	36	0.367 (0.139-0.964)	0.042
OS at 3 yr (%)	81.0	48.2
Stage IIB	24	15
PFS (mo)	48	23	0.335 (0.117-0.953)	0.041
OS (mo)	Undefined	29	0.118 (0.029-0.484)	0.003
Without NAC	11	8
PFS (mo)	48	23	0.637 (0.175-2.322)	0.494
OS (mo)	Undefined	36	0.032 (0.053-1.869)	0.203

CCRT, concurrent chemoradiotherapy; HR, hazard ratio; NAC, neoadjuvant chemotherapy; OS, overall survival; PFS, progression-free survival.

^*Log rank test.